Highlights Simris Group AB

Equities

SIMRIS B

SE0008091664

Market Closed - Nasdaq Stockholm Other stock markets 11:19:02 2024-05-23 am EDT			5-day change	1st Jan Change
0.26 ^SEK	+1.56%		+75.68%	+15.56%

May. 15	Simris Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 15	Simris Group AB Enters into Amended Agreement to Extend the Term of the Flexible Funding Facility with The Brand Laboratories FZ	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Simris Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Simris Group AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Simris Group AB Signs Head of Terms for an Offtake Agreement Valued At Minimum ?2 Million / SEK 22 Million	Jan. 10	CI
Simris Group AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Simris Appoints Reviate LLC as Exclusive Distributor	Nov. 07	CI
Simris Group AB Confirms New Patent Application from Its Adc-Payload Platform	23-08-02	CI
Simris Group AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-24	CI
Simris Alg AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI
Simris Group AB Broadens Distribution of Its Reformulated Algal Omega-3 Products	23-04-28	CI
Simris Alg AB Signs Partnership Agreement with Lonza Ltd to Promote its ADC Payload Technology	23-02-28	CI
Simris Alg AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-15	CI
Simris Alg AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Simris Alg AB (OM:SIMRIS B) acquired 100% of the shares in Cyano Biotech GmbH.	22-08-24	CI
Simris Alg AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-17	CI
Simris Alg AB (OM:SIMRIS B) entered into a binding Letter Of Intent to acquire 100% of the shares in Cyano Biotech GmbH.	22-08-16	CI
Simris Alg AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-22	CI
Simris Alg AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-16	CI
Simris Alg AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-16	CI
Simris set for commercial acceleration in 2022 \| See interview with Chairman Steven Schapera	21-12-16	AQ
Simris Alg AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Simris Group AB

Equities

SIMRIS B

SE0008091664

Highlights

Filters